ERCC1 C8092A polymorphism predicts fair survival outcome in Japanese patients with pharyngo-laryngeal squamous cell carcinoma-Reference-Cited by-同舟云学术

ERCC1 C8092A polymorphism predicts fair survival outcome in Japanese patients with pharyngo-laryngeal squamous cell carcinoma

Published:2019-11-20 Issue:2 Volume:277 Page:601-610
ISSN:0937-4477
Container-title:European Archives of Oto-Rhino-Laryngology
language:en
Short-container-title:Eur Arch Otorhinolaryngol

Author:

Hirakawa Hitoshi^ORCID,Ikegami Taro,Azechi Satoe,Agena Shinya,Uezato Jin,Kinjyo Hidetoshi,Yamashita Yukashi,Tanaka Katsunori,Kondo Shunsuke,Maeda Hiroyuki,Suzuki Mikio,Gahana Akira

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Otorhinolaryngology

Link

http://link.springer.com/content/pdf/10.1007/s00405-019-05731-y.pdf

Reference40 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

2. Kohno N, Kitahara S, Tamura E, Tanabe T (2002) Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer. Oncology 63(3):226–331

3. Lin SS, Massa ST, Varvares MA (2016) Improved overall survival and mortality in head and neck cancer with adjuvant concurrent chemoradiotherapy in national databases. Head Neck 38(2):208–215

4. Chitapanarux I, Tharavichitkul E, Lorvidhaya V, Sittitrai P, Pattarasakulchai T (2010) Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancer. Biomed Imaging Interv J 6(3):e23

5. Jain P, Kumar P, Pai VR, Parikh PM (2008) Neoadjuvant chemotherapy or chemoradiotherapy in head and neck cancer. Indian J Cancer 45(3):83–89

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between XRCC1 Arg399Gln polymorphism with prognosis of head and neck squamous cell carcinomas: A meta-analysis;Heliyon;2023-10

2. Survival association of XRCC1 for patients with head and neck squamous cell carcinoma: A systematic review and meta-analysis;Frontiers in Genetics;2023-01-05

3. Gene polymorphisms and prognosis of head and neck squamous cell carcinoma: a systematic review;Reports of Practical Oncology and Radiotherapy;2022-12-29

4. 頸部郭清術における副損傷の予防と対応;Nippon Jibiinkoka Gakkai Kaiho;2021-07-20

5. Growth Arrest Specific Gene 6 Promotes Proliferation and Invasion of Laryngeal Cancer Cells Through the Vascular Endothelial Growth Factor (VEGF)/Protein Kinase B (AKT) Pathway;J BIOMATER TISS ENG;2020